Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by upinzmokeon Mar 15, 2017 6:32am

127 Views

Post# 25980712

RE:RE:RE:NF pot suspected in syphilis outbreak

Wow. You are 12 years old or are severely mentally challenged to post such absurd info on this board
why do you bother to waste you time putting up such stupid posts
Do you really believe any adult would take anything you post seriously
hey whatever turns your crank
if this is how you like spending your time go for it
All your doing is proving to everyone that comes here is that there is something wrong with you

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario